In a report issued by the directors of Germany's Degussa, the company noted that (subject to final approval by the administration board of the Treuhand eastern German privatization agency and by the anti-trust authorities) Degussa is acquiring Arzneimittelwerk Dresden GmbH.
The statement said that Degussa's affiliate Asta Medica AG won the bid under an internationalization privatization tender sponsored by the Treuhand. With 2,000 employees and sales of over 400 million Deutschemarks ($263.9 million), AWD is the largest producer of pharmaceuticals in eastern Germany. The company focuses principally on treatments for cardiovascular, gastrointestinal, rheumatic and central nervous system disorders.For Asta, this acquisition represents an entree into the market for branded generics and expansion into the new eastern sector.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze